MedPath

DMT-310

Generic Name
DMT-310

DMT310-009 Topical in the Treatment of Acne Vulgaris

Phase 3
Recruiting
Conditions
Acne Vulgaris
Interventions
Drug: Placebo
First Posted Date
2023-10-19
Last Posted Date
2023-12-21
Lead Sponsor
Dermata Therapeutics
Target Recruit Count
555
Registration Number
NCT06090721
Locations
🇺🇸

Center for Dermatology Clinical Research, Inc., Fremont, California, United States

🇺🇸

DermResearch, Austin, Texas, United States

DMT310-003 Topical in the Treatment of Acne Vulgaris

Phase 2
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Placebo
First Posted Date
2019-09-27
Last Posted Date
2020-07-22
Lead Sponsor
Dermata Therapeutics
Target Recruit Count
181
Registration Number
NCT04106778
Locations
🇺🇸

Dermata Investigational Site, Austin, Texas, United States

DMT310-001 Topical in the Treatment of Acne Vulgaris

Phase 2
Completed
Conditions
Acne Vulgaris
Interventions
First Posted Date
2018-05-25
Last Posted Date
2020-07-22
Lead Sponsor
Dermata Therapeutics
Target Recruit Count
121
Registration Number
NCT03536637
Locations
🇺🇸

Dermata Investigational Site, Katy, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath